June 12 (Reuters) - Medtronic PLC:
* MEDTRONIC ANNOUNCES A $337 MILLION PRODUCT INVESTMENT FROM BLACKSTONE LIFE SCIENCES TO EXPAND DEVELOPMENT OF FUTURE DIABETES TECHNOLOGIES
* MEDTRONIC PLC - MEDTRONIC IS NOT DISCLOSING SPECIFIC DEVELOPMENT PROGRAMS
* MEDTRONIC - IF SUCCESSFULLY COMMERCIALIZED, CO TO PAY ROYALTIES EXPECTED TO BE IN LOW- TO MID-SINGLE DIGIT RANGE AS % OF SALES
* MEDTRONIC PLC - WILL RECEIVE UP TO $337 MILLION IN FUNDING OVER NEXT SEVERAL YEARS TO FUND FOUR IDENTIFIED DIABETES RESEARCH AND DEVELOPMENT PROGRAMS
* MEDTRONIC PLC - ADDITIONAL TERMS OF ARRANGEMENT WERE NOT DISCLOSED. Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.